IRLAB announces that equity research company Edison initiates coverage of the company

June 2, 2021

IRLAB (Nasdaq Stockholm: IRLAB A) today announced that equity research company Edison Investment Research has been engaged by IRLAB to produce regular, in-depth research on the company. The intention is to raise the visibility of the company and enable investors and stakeholders to develop an improved understanding of the business.

IRLAB (Nasdaq Stockholm: IRLAB A) today announced that equity research company Edison Investment Research has been engaged by IRLAB to produce regular, in-depth research on the company. The intention is to raise the visibility of the company and enable investors and stakeholders to develop an improved understanding of the business.

Edison's research is read on a free-to-access basis by individuals and institutions across the globe. Edison's coverage of IRLAB is available on IRLAB’s website, www.irlab.se, as well as on Edison’s website, www.edisongroup.com/company/irlab-therapeutics.

“It is important that investors are given the opportunity to acquire different perspectives on IRLAB’s operations and the value potential of IRLAB’s share. Engaging Edison is part of our commitment to increase analyst coverage of the company and will be followed by additional research from other banks and analysts ahead,” said Viktor Siewertz, CFO at IRLAB.